No takes yet. Share an insight, caveat, or question.
Preclinical genomic analysis reveals clone-specific DNA replication timing in breast and ovarian cancers, highlighting how copy number alterations alter subclone fitness.
Weiner et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: